Hareem Arif
Psychiatry · Bowling Green, KYNPI 1134757974
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,538, 7.4 times the $342 reported in 2022.
Across 192 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$644
- AbbVie$595
- Axsome Therapeutics, Inc.$453
- Johnson & Johnson$443
- Otsuka America Pharmaceutical, Inc.$401
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$376
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,912 in reported general payments places this provider in the 80th percentile of 348 psychiatry providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 16 | $27,469 |
| VraylarCariprazine Hcl | 13 | $19,595 |
| SpravatoEsketamine Hcl | 14 | $15,785 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $12,569 |
| Lurasidone Hcl | 18 | $4,474 |
| Aripiprazole | 50 | $3,959 |
| Divalproex Sodium ErDivalproex Sodium | 20 | $2,638 |
| Quetiapine Fumarate | 120 | $2,484 |
| Duloxetine Hcl | 122 | $2,363 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 20 | $1,733 |
| Ziprasidone Hcl | 17 | $1,578 |
| Doxepin Hcl | 33 | $1,411 |
| Trazodone Hcl | 114 | $1,377 |
| Buspirone Hcl | 102 | $1,325 |
| Clozapine | 20 | $1,295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $376 | $27,46916 claims |
| AbbVieVraylar | $595 | $19,59513 claims |
| Johnson & JohnsonSpravato | $443 | $15,78514 claims |
| Axsome Therapeutics, Inc.Auvelity | $453 | $12,56911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 348 psychiatry providers in Kentucky.
Other psychiatry in Bowling Green
- Joseph GrauBowling Green$10K
- Arvinder ChaniBowling Green$5K
- Carmen PintoElizabethtown$1.7M
- Rifaat El-MallakhLouisville$1.6M
- Robert StewartLouisville$651K
- Mark WrightLexington$637K
- Carol MillerFrankfort$462K
- Ali FarooquiLouisville$393K
- Steven CroleyLexington$151K
- Joseph HarrisonOwensboro$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.